PHASE-I CLINICAL-TRIAL WITH AMETANTRONE (NSC-287513)

被引：22
|
作者：
PICCART, M
ROZENCWEIG, M
ABELE, R
CUMPS, E
DODION, P
DUPONT, D
KISNER, D
KENIS, Y
机构：
[1] UNIV LIBRE BRUXELLES,INST JULES BORDET,CTR TUMEURS,DEPT CHEMOTHERAPY,SERV MED,B-1000 BRUSSELS,BELGIUM
[2] UNIV LIBRE BRUXELLES,INST JULES BORDET,CTR TUMEURS,CLIN HJ TAGNON,INVEST LAB,B-1000 BRUSSELS,BELGIUM
来源：
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1981年 / 17卷 / 07期
关键词：
D O I：
10.1016/0014-2964(81)90233-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：775 / 779
页数：5
相关论文
共 50 条
  • [1] A PHASE-I TRIAL OF AMETANTRONE ACETATE (NSC-287513)
    GAMS, RA
    OSTROY, F
    BENDER, JF
    GRILLOLOPEZ, AJ
    INVESTIGATIONAL NEW DRUGS, 1985, 3 (04) : 383 - 388
  • [2] PHASE-I CLINICAL-TRIAL WITH ANTHRACENEDIONE DIACETATE (DAD) (NSC-287513)
    PICCART, M
    ABELE, R
    CUMPS, E
    DODION, P
    DUPONT, D
    KENIS, Y
    ROZENCWEIG, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 192 - 192
  • [3] PHARMACOKINETICS OF AMETANTRONE ACETATE (NSC-287513)
    KUHN, JG
    BALMER, CE
    LUDDEN, TM
    LOESCH, DM
    VONHOFF, DD
    BENDER, JF
    GRILLOLOPEZ, AJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 19 (02) : 133 - 137
  • [4] PHASE-I CLINICAL-TRIAL OF MERBARONE (NSC 336628)
    KRAUT, EH
    GREVER, MR
    STAUBUS, AE
    MALSPEIS, L
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 191 - 191
  • [5] PHASE-I CLINICAL-TRIAL OF ORMAPLATIN (TETRAPLATIN, NSC-363812)
    OROURKE, TJ
    WEISS, GR
    NEW, P
    BURRIS, HA
    RODRIGUEZ, G
    ECKHARDT, J
    HARDY, J
    KUHN, JG
    FIELDS, S
    CLARK, GM
    VONHOFF, DD
    ANTI-CANCER DRUGS, 1994, 5 (05) : 520 - 526
  • [6] PHASE-I CLINICAL-TRIAL OF SPIROGERMANIUM
    SCHEIN, PS
    SLAVIK, M
    SMYTHE, T
    HOTH, D
    SMITH, F
    MACDONALD, JS
    WOOLLEY, PV
    CANCER TREATMENT REPORTS, 1980, 64 (10-1): : 1051 - 1056
  • [7] PHASE-I CLINICAL-TRIAL WITH CARBETIMER
    DODION, P
    DEVALERIOLA, D
    BODY, JJ
    HOUA, M
    NOEL, P
    ABRAMS, J
    CRESPEIGNE, N
    WERY, F
    KENIS, Y
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (02): : 279 - &
  • [8] PHASE-I CLINICAL-TRIAL OF CARBETIMER
    HANAUSKE, AR
    MELINK, TJ
    HARMAN, GS
    CLARK, GM
    CRAIG, JB
    KOELLER, JM
    BOLDT, DH
    KANTOR, B
    KISNER, DL
    ORCZYK, G
    ANDERSON, DW
    PAGET, E
    SAROSY, GA
    VONHOFF, DD
    CANCER RESEARCH, 1988, 48 (18) : 5353 - 5357
  • [9] PHASE-I CLINICAL-TRIAL OF MITOZOLOMIDE
    NEWLANDS, ES
    BLACKLEDGE, G
    SLACK, JA
    GODDARD, C
    BRINDLEY, CJ
    HOLDEN, L
    STEVENS, MFG
    CANCER TREATMENT REPORTS, 1985, 69 (7-8): : 801 - 805
  • [10] PHASE-I CLINICAL-TRIAL OF SPIROGERMANIUM
    BYRNE, PJ
    SCHEIN, PS
    MAGUIRE, P
    HOTH, D
    SMITH, F
    BROWN, J
    WOOLLEY, PV
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 351 - 351
12345